---
title: "Henlius Biotech Gets China Nod for Tumor Drug Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277936517.md"
description: "Henlius Biotech Gets China Nod for Tumor Drug Trial"
datetime: "2026-03-05T12:38:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277936517.md)
  - [en](https://longbridge.com/en/news/277936517.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277936517.md)
---

# Henlius Biotech Gets China Nod for Tumor Drug Trial



### Related Stocks

- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [02696.HK](https://longbridge.com/en/quote/02696.HK.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)

## Related News & Research

- [Sino Biopharmaceutical Unit Enrolls First Patient in Gastric Cancer Drug Trial](https://longbridge.com/en/news/282827241.md)
- [Henlius Biotech Doses First Patient in Breast Cancer Drug Study](https://longbridge.com/en/news/282326155.md)
- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)
- [AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid](https://longbridge.com/en/news/282533515.md)
- [Ascletis Pharma Selects Oral Obesity Drug Combination for Clinical Development](https://longbridge.com/en/news/281968452.md)